If you compare VAST with (say) Phylogica - a similar kind of discovery platform, though further advanced in collaborations/partnerships - then it's hard to value this as worth more than $5 million or so, maybe 1 or 2 cents per share.
astrazeneca multi-target drug discovery collab, page-18
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable